The mission of the West Virginia Division of Tuberculosis Elimination is to achieve the absence of indigenous transmission of tuberculosis infection in West Virginia, which results in clinically apparent tuberculosis disease.
The DTBE provides tuberculin testing materials to Local Health Departments for contacts and other high risk persons. We also provide x-rays for evaluation of active disease and latent TB infection (LTBI) through Local Health Departments. Clinicians are provided for chest diagnostic clinics to evaluate/treat active disease and LTBI. We provide medications as well as financial support to Local Health Departments to do Liver Function Tests for TB cases and LTBI patients. We work with the Office of Laboratory Services to provide AFB smear and culture testing, drug susceptibilities and DNA fingerprinting of specimens.
Click Here for More Information on Facebook and Twitter Messages
UPDATE OCTOBER 11, 2013: See the important memo below which provides guidance regarding the PPD shortage:
Important PPD Shortage Guidance Memo, Oct. 11, 2013
Letter of Deferral (PPD Shortage Letter)
TB-104 Risk Assessment
Important Note, Sept. 17, 2013: There is currently a nationwide shortage of PPD. A memo has been sent to all local health departments regarding this. See the Dear Colleague Letter below for important information and resources on this:
Dear Colleague Letter
CDC: MMWR Recommendations
MMWR, Dec 16, 2005 / 54(RR15);1-37. "Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis"
MMWR, Dec 30, 2005 / Vol. 54 / No. RR-17. "Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005"
MMWR, June 20, 2003 / Vol. 52 / No. RR-11. "Treatment of Tuberculosis"